Dishman Pharmaceuticals and Chemicals has posted a 44.49 per cent dip in consolidated net profit to Rs 15.12 crore for the quarter ended June 30, 2011.
The net profit stood at Rs 27.24 crore during the same period in the previous financial year, Dishman Pharmaceuticals said in a filing to the Bombay Stock Exchange.
Total income rose to Rs 242.77 crore from Rs 212.27 crore.
Meanwhile, the company shares were being quoted at Rs 89 in the late afternoon trade on the BSE, down 1.87 per cent from the previous close.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.